What is the ICD-10 code for bladder retention?

The ICD-10 code for bladder retention varies based on the cause: R33.0 for drug-induced, R33.8 for other specified causes, and R33.9 for unspecified retention.

How do you code drug-induced urinary retention?

Code R33.0 for drug-induced urinary retention, and include an additional code from T36-T50 to specify the drug causing the adverse effect.

ICD-10 Coding for Bladder Retention(R33.0, N40.1, R33.8)

Save

Explore comprehensive ICD-10 coding guidelines for bladder retention, including drug-induced and unspecified causes. Learn about documentation requirements and coding pitfalls.

Also known as:

Urinary RetentionInability to Urinate

Related ICD-10 Code Ranges

Complete code families applicable to Bladder Retention

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
R33.0	Drug-induced urinary retention	Use when urinary retention is directly attributed to a specific drug.	Temporal relationship between drug initiation and retention Naranjo adverse drug reaction probability score ≥4
R33.8	Other retention of urine	Use when retention is due to a known cause other than drugs.	Postvoid residual ≥300mL via bladder scan Urodynamic confirmation of detrusor underactivity
R33.9	Unspecified retention of urine	Use when no specific cause for retention is identified.	Retention persists after ruling out obstruction neurological and pharmacologic causes
R39.14	Incomplete bladder emptying	Use when there is a subjective report of incomplete emptying without objective retention.	IPSS score ≥8 Uroflowmetry Qmax <10mL/sec with interrupted flow

Primary ICD-10-CM Codes

Drug induced retention of urine

R33.0Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Unspecified urinary retentionR33.9

Other retention of urineR33.8

Documentation & Coding Risks

Avoid these common issues when documenting Bladder Retention.

Omitting drug name in drug-induced retention

Impact

Clinical: May lead to inappropriate treatment adjustments., Regulatory: Non-compliance with coding standards., Financial: Potential denial of claims due to incomplete coding.

Mitigation

Always include drug name and dosage in documentation, Review medication history thoroughly

Using R33.9 when a specific cause is documented

Impact

Reimbursement: May lead to incorrect DRG assignment and affect reimbursement., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Decreases accuracy of clinical data.

Mitigation

Use R33.8 or R33.0 with appropriate documentation of the cause.

Failure to sequence N40.1 before R33.8 in BPH-related retention

Impact

Reimbursement: Incorrect sequencing can affect DRG and reimbursement., Compliance: Violates coding sequencing rules., Data Quality: Impacts data integrity and clinical reporting.

Mitigation

Ensure N40.1 is coded first when BPH is the primary cause.

Specificity in coding urinary retention

Impact

High error rates in coding unspecified retention when specific causes are documented.

Mitigation

Implement thorough documentation reviews and coder training.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with R33.0.

Primary Code

R33.0

Drug induced retention of urine

Quick Navigation

ICD-10 codes5

Coding risks4

FAQs2

ICD-10 Coding for Bladder Retention(R33.0, N40.1, R33.8)

Documentation & Coding Risks

Frequently Asked Questions

What is the ICD-10 code for bladder retention?

How do you code drug-induced urinary retention?

Related condition guides